These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10099827)
1. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. Pruschy M; Wirbelauer C; Glanzmann C; Bodis S; Krek W Cell Growth Differ; 1999 Mar; 10(3):141-6. PubMed ID: 10099827 [TBL] [Abstract][Full Text] [Related]
2. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK; Liu TJ; Frederick MJ; Clayman GL Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J; Hiebert SW Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734 [TBL] [Abstract][Full Text] [Related]
5. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Meng RD; Phillips P; El-Deiry WS Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Li WW; Fan J; Hochhauser D; Bertino JR Cancer Res; 1997 Jun; 57(11):2193-9. PubMed ID: 9187120 [TBL] [Abstract][Full Text] [Related]
7. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis. Canman CE; Kastan MB Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869 [TBL] [Abstract][Full Text] [Related]
8. Functional roles of E2F in cell cycle regulation. Fan J; Bertino JR Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768 [TBL] [Abstract][Full Text] [Related]
9. Control of E2F activity by p21Waf1/Cip1. Delavaine L; La Thangue NB Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892 [TBL] [Abstract][Full Text] [Related]
10. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
12. Role for E2F in DNA damage-induced entry of cells into S phase. Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kato T; Yuan ZM Cancer Res; 1997 Sep; 57(17):3640-3. PubMed ID: 9288762 [TBL] [Abstract][Full Text] [Related]
13. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol. Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161 [TBL] [Abstract][Full Text] [Related]
14. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins. Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883 [TBL] [Abstract][Full Text] [Related]
17. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992 [TBL] [Abstract][Full Text] [Related]
18. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Liu Y; Zacksenhaus E Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430 [TBL] [Abstract][Full Text] [Related]
20. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas. Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]